Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-16-064310
Filing Date
2016-05-10
Accepted
2016-05-10 16:31:18
Documents
37
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP. 10-Q 3-31-2016 form10q.htm 10-Q 419493
2 EXHIBIT 31 ex31.htm EX-31 11492
3 EXHIBIT 32 ex32.htm EX-32 5535
  Complete submission text file 0001140361-16-064310.txt   2847958

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bstc-20160331.xml EX-101.INS 506109
5 XBRL TAXONOMY EXTENSION SCHEMA bstc-20160331.xsd EX-101.SCH 22204
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20160331_cal.xml EX-101.CAL 37102
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20160331_def.xml EX-101.DEF 87894
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20160331_lab.xml EX-101.LAB 377601
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20160331_pre.xml EX-101.PRE 215553
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 161636213
SIC: 2834 Pharmaceutical Preparations